Furthermore, in contrast to influenza, interferon response against SARS-CoV-2 induced by CD8+ TRM cells does not decline with age (14) and nasal CD8+ TRM cells can last at least two months after virus clearance (31), indicating the persistence of TRM cells against SARS-CoV-2. The gene discussed is CD8A; the disease is influenza.